
Cipla Warehouse Licence Cancelled in Pune
The story in brief
Maharashtra Food and Drug Administration revoked Cipla Pharma’s warehouse licence in Pune after an inspection found violations in drug labelling, storage, and records. The cancellation followed a regulatory process aligned with Bombay High Court directions, impacting Cipla’s operations and drug supply. The FDA emphasized ensuring medicine safety and compliance across the supply chain.